Evidence map›Paper›PMID 42774472›Full record

ReviewFrontiers in pharmacology2026

Therapeutic effect of ginseng: a non-antibiotic approach to preventing pathogenic bacterial infections and restoring gut microbiota composition.

Seong-Hyeon Kim, Changhan Lee

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Seong-Hyeon KimDepartment of Biological Sciences, Ajou University, Suwon, Republic of Korea.
Changhan LeeDepartment of Biological Sciences, Ajou University, Suwon, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human health is influenced by various factors, including bacteria that surround us ubiquitously. Bacteria constituting normal microbiota of various human body niches, primarily the gut, can confer beneficial effects by aiding food digestion, improving nutrient production, and preventing pathogen colonization. However, bacteria can also have harmful effects as pathogens, especially when the immune system is compromised due to various diseases. In particular, secondary or co-infections caused by pathogenic bacteria have been shown to significantly contribute to illness severity and increased mortality rates. Ginseng, an herb widely used for various medicinal purposes in Asia, including the treatment of cancer and immune-related diseases, has shown substantial effects in modulating the bacterial composition of the human body, including protecting human health against various pathogenic bacterial infections. Furthermore, recent studies have also demonstrated that ginseng can promote the restoration of disrupted gut microbiota composition, caused by various reasons such as intestinal inflammation, obesity, antibiotics-associated diarrhea, colitis and so on. Therefore, this review comprehensively discusses the effects of ginseng on pathogenic bacteria, as well as the recent findings on the impact of ginseng on gut microbiota imbalances caused by various factors.

Indexed as

acidic polysaccharidesgingsengginsenosidegut microbiotapathogenic bacterial infection

Identifiers

PMID42774472
PMCPMC13594583

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.